InMed Pharmaceuticals Inc. (INM) Insider Trading Disclosures
InMed Pharmaceuticals Inc. (INM) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INM
CIK: 1728328
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 6/30/2025 12:00:00 AM
Lead Engagement PartnerMatthew Jahrsdoerfer
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-15 | 2026-10-13 | PRIMARY DOCUMENT | 0001940272-26-000025 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | PRIMARY DOCUMENT | 0001940272-26-000023 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0001104659-26-114415 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | PRIMARY DOCUMENT | 0001940272-26-000022 | View SEC Doc Filr Page |
| EFFECT | 2026-10-01 | — | EFFECT Filing | 9999999995-26-003126 | View SEC Doc Filr Page |
| 424B3 | 2026-10-01 | — | 424B3 | 0001193125-26-410691 | View SEC Doc Filr Page |
| S-4/A | 2026-09-29 | — | S-4/A | 0001193125-26-407792 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-16 | CURRENT REPORT | 0001213900-26-101492 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | PRIMARY DOCUMENT | 0001940272-26-000021 | View SEC Doc Filr Page |
| S-4/A | 2026-09-09 | — | S-4/A | 0001193125-26-386611 | View SEC Doc Filr Page |
| 425 | 2026-09-09 | — | FORM 425 | 0001213900-26-098432 | View SEC Doc Filr Page |
| 10-K | 2026-09-09 | 2026-06-30 | ANNUAL REPORT | 0001213900-26-098419 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001193125-26-352958 | View SEC Doc Filr Page |
| 425 | 2026-07-22 | — | FORM 425 | 0001213900-26-080423 | View SEC Doc Filr Page |
| 425 | 2026-07-22 | — | CURRENT REPORT | 0001213900-26-080417 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-22 | CURRENT REPORT | 0001213900-26-080414 | View SEC Doc Filr Page |
| 425 | 2026-07-20 | — | FORM 425 | 0001213900-26-079635 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | PRIMARY DOCUMENT | 0001940272-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-14 | 4 Filing | 0001213900-26-078891 | View SEC Doc Filr Page |
| 425 | 2026-07-10 | — | CURRENT REPORT | 0001213900-26-077132 | View SEC Doc Filr Page |
| 8-K | 2026-07-10 | 2026-07-06 | CURRENT REPORT | 0001213900-26-077127 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 Filing | 0001213900-26-075144 | View SEC Doc Filr Page |
| S-4 | 2026-07-02 | — | S-4 | 0001193125-26-294455 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-06-10 | — | SCHEDULE 13D Filing | 0001213900-26-067514 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-05-20 | 4 Filing | 0001213900-26-067505 | View SEC Doc Filr Page |